2025年全球医药仓储服务市场报告

预计未来几年，药品稳定性储存服务市场规模将强劲成长。至2029年，该市场规模将成长至36.5亿美元，复合年增长率为6.5%。预测期内的成长主要归因于个人化医疗的兴起、低温运输物流的扩展、生物製药产品线的增加、生物製药核准的增加以及稳定性测试需求的不断增长。这段时期的主要趋势包括技术进步、低温储存技术的进步、数位监控技术的发展、包装技术的创新以及温控储存系统的进步。

预计未来新药核准数量的增加将推动药品稳定性储存服务市场的扩张。新药是指新开发的、过去未获核准或上市的药物化合物。新药新药认证数量的激增很大程度上得益于生物技术的进步，生物技术使得新化合物的发现成为可能，监管流程的改进也促进了更快、更有效率的药物开发。新药认证数量的增加将推动对药品稳定性储存服务的需求，这些服务旨在确保这些产品的适当条件、合规性和长期储存管理。例如，美国食品药物管理局(FDA) 在 2023 年 10 月报告称，2022 年核准了37 种新药，2024 年核准了50 种新药，这将推动癌症、罕见疾病、神经病学、感染疾病、思觉失调症、疼痛、阿兹海默症疾病的治疗。因此，新药核准数量的增加正在推动药品稳定性储存服务市场的成长。

药品稳定性储存服务市场的主要企业正专注于开发技术先进的解决方案，例如低温储存套件，以延长对温度敏感的药品的保质期。低温储存套件是专用设施，可维持极低的温度，通常低于-150°C，以保存对温度敏感的生物和药物材料，例如细胞疗法、疫苗和生技药品。例如，2024 年 12 月，总部位于英国的稳定性和生物样本储存公司 Astoriom 宣布在其位于爱尔兰沃特福德郡的 Tramore 工厂建立一个低温储存套件。此次扩建将显着提高生物样本的储存容量，并提供低至-196°C 的精确温度控制、大储存容量、符合法规的 ISO9001 认证以及门禁和监控系统等先进的安全功能，以确保安全的长期储存。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球医药仓储服务PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球医药稳定储存服务市场：成长率分析
• 全球医药稳定性服务市场表现：规模与成长，2019-2024
• 全球药物稳定性服务市场预测：规模与成长，2024-2029 年，2034 年
• 全球药物稳定性服务总目标市场（TAM）

第六章市场区隔

• 全球医药仓储服务市场：依服务、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 稳定
• 贮存
• 全球药品稳定性服务市场：依产品类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 药片
• 胶囊
• 注射液
• 口服悬浮液
• 组合产品
• 其他产品类型
• 全球药物稳定性服务市场（依分子、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 小分子
• 高分子
• 全球医药仓储服务市场模式、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 内部
• 外包
• 全球医药储存服务市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
• 生物製药公司
• 契约製造组织
• 合约研究组织
• 其他最终用户
• 全球医药稳定服务市场、稳定服务细分、按类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 长期稳定性测试
• 加速稳定性测试
• 中期稳定性测试
• 光稳定性测试
• 强制劣化研究
• 全球医药仓储服务市场仓储服务细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 常温保存
• 冷藏保存（2℃至8℃）
• 冷冻保存（-20℃至-80℃）
• 低温储存（-150℃至-196℃）
• 管制物质和产品的储存

第七章 区域和国家分析

• 全球医药仓储服务市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球医药仓储服务市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 药品稳定储存服务市场：竞争格局
• 药品稳定储存服务市场：公司简介
  • Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Intertek Group plc
• Element Materials Technology Inc
• Alloga UK Ltd.
• ALS Limited
• Pharmaceutical Contract Industries Pharma Services.
• Almac Group
• Alcami Corporation
• BioLife Solutions Inc.
• Auriga Research Private Limited
• Reading Scientific Services Ltd.
• Lucideon Limited
• Q Laboratories Inc
• PD Partners
• Precision Stability Storage
• Roylance Stability Storage Limited

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年药品稳定储存服务市场：提供新机会的国家
• 2029年药品稳定储存服务市场：细分市场带来新机会
• 2029年药品稳定储存服务市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Pharmaceutical stability and storage services are specialized offerings designed to ensure that pharmaceutical products, including drugs, medications, and vaccines, retain their quality, efficacy, and safety throughout their shelf life. These services involve maintaining controlled storage environments, conducting stability studies to monitor chemical, physical, and microbiological changes, and ensuring compliance with regulatory standards.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary pharmaceutical stability and storage services include stability testing and storage solutions. Stability services evaluate how pharmaceutical products maintain their quality, potency, and safety under varying environmental conditions over time. These services apply to various products such as tablets, capsules, injectable solutions, oral suspensions, combination products, and others, and can involve both small and large molecules. Stability and storage services are provided through in-house and outsourcing models, and are utilized by biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and other entities.

The pharmaceutical stability and storage services market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical stability and storage services market statistics, including pharmaceutical stability and storage services industry global market size, regional shares, competitors with a pharmaceutical stability and storage services market share, detailed pharmaceutical stability and storage services market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical stability and storage services industry. This pharmaceutical stability and storage services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth observed during the historic period can be attributed to the rising demand for biologics, the increasing prevalence of chronic diseases, growth in drug development, the growing complexity of drug formulations, and heightened research and development efforts within the pharmaceutical industry.

The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth projected during the forecast period can be attributed to the rise of personalized medicine, the expansion of cold chain logistics, a growing biopharma pipeline, increasing biologic drug approvals, and a higher demand for stability testing. Key trends during this period include technological advancements, progress in cryogenic storage technologies, developments in digital monitoring technologies, innovations in packaging technologies, and the advancement of temperature-controlled storage systems.

The growing number of novel drug approvals is expected to drive the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is a newly developed pharmaceutical compound that has not been previously approved for use or marketed. The surge in novel drug approvals is largely attributed to advancements in biotechnology, which have enabled the discovery of new compounds, as well as improvements in regulatory processes that facilitate faster and more efficient drug development. The increase in novel drug approvals boosts the demand for pharmaceutical stability and storage services, which ensure the proper conditions, compliance, and extended shelf-life management of these products. For example, in October 2023, the U.S. Food and Drug Administration (FDA) reported that 37 novel drugs were approved in 2022, followed by 50 in 2024, advancing treatments in areas such as cancer, rare diseases, neurology, infections, and conditions such as schizophrenia, pain, and Alzheimer's. As such, the rising number of novel drug approvals is fueling the growth of the pharmaceutical stability and storage services market.

Leading companies in the pharmaceutical stability and storage services market are focusing on the development of technologically advanced solutions, such as cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, to preserve temperature-sensitive biological and pharmaceutical materials such as cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage company, unveiled a cryogenic storage suite at its Tramore facility in County Waterford, Ireland. This expansion significantly enhances its capacity to store biological samples, offering precise temperature control down to -196°C, large storage capacity, ISO 9001 certification for regulatory compliance, and advanced security features, such as access controls and monitoring systems, to ensure safe long-term preservation.

In June 2022, Cambrex Corporation, a US-based contract development and manufacturing organization, acquired Q1 Scientific for an undisclosed amount. This acquisition allows Cambrex to expand its presence in Europe, bolster its stability storage service capabilities, and strengthen its portfolio of outsourced pharmaceutical solutions to meet the growing demands of the industry. Q1 Scientific Limited, based in Ireland, specializes in providing pharmaceutical stability and storage services.

Major players in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited.

North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical stability and storage services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical stability and storage services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical stability and storage services market consists of revenues earned by entities by providing services such as photostability testing, cold chain management, disaster recovery and backup storage. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical stability and storage services market also includes sales of stability chambers, cryogenic storage systems, cold storage units and automated sample management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Stability And Storage Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical stability and storage services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical stability and storage services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical stability and storage services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Stability; Storage
• 2) By Product Type: Tablets; Capsules; Injectable Solutions; Oral Suspensions; Combination Products; Other Product Types
• 3) By Molecule: Small Molecule; Large Molecule
• 4) By Mode: In-House; Outsourcing
• 5) By End User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Other End Users
• Subsegments:
• 1) Stability Services: Long-Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing; Forced Degradation Studies
• 2) Storage Services: Ambient Storage; Refrigerated Storage (2°C to 8°C); Frozen Storage (-20°C to -80°C); Cryogenic Storage (-150°C to -196°C); Controlled Drug Substance And Product Storage
• Companies Mentioned: Cencora Inc; SGS S.A.; Eurofins Scientific SE; Catalent Inc; Charles River Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Stability And Storage Services Market Characteristics

3. Pharmaceutical Stability And Storage Services Market Trends And Strategies

4. Pharmaceutical Stability And Storage Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Stability And Storage Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Stability And Storage Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Stability And Storage Services Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Stability And Storage Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Stability And Storage Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Stability And Storage Services Total Addressable Market (TAM)

6. Pharmaceutical Stability And Storage Services Market Segmentation

• 6.1. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stability
• Storage
• 6.2. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectable Solutions
• Oral Suspensions
• Combination Products
• Other Product Types
• 6.3. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.4. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourcing
• 6.5. Global Pharmaceutical Stability And Storage Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Contract Research Organizations
• Other End Users
• 6.6. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Stability Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-Term Stability Studies
• Accelerated Stability Studies
• Intermediate Stability Studies
• Photostability Testing
• Forced Degradation Studies
• 6.7. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Storage Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambient Storage
• Refrigerated Storage (2°C to 8°C)
• Frozen Storage (-20°C to -80°C)
• Cryogenic Storage (-150°C to -196°C)
• Controlled Drug Substance And Product Storage

7. Pharmaceutical Stability And Storage Services Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Stability And Storage Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Stability And Storage Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Stability And Storage Services Market

• 8.1. Asia-Pacific Pharmaceutical Stability And Storage Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Stability And Storage Services Market

• 9.1. China Pharmaceutical Stability And Storage Services Market Overview
• 9.2. China Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Stability And Storage Services Market

• 10.1. India Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Stability And Storage Services Market

• 11.1. Japan Pharmaceutical Stability And Storage Services Market Overview
• 11.2. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Stability And Storage Services Market

• 12.1. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Stability And Storage Services Market

• 13.1. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Stability And Storage Services Market

• 14.1. South Korea Pharmaceutical Stability And Storage Services Market Overview
• 14.2. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Stability And Storage Services Market

• 15.1. Western Europe Pharmaceutical Stability And Storage Services Market Overview
• 15.2. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Stability And Storage Services Market

• 16.1. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Stability And Storage Services Market

• 17.1. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Stability And Storage Services Market

• 18.1. France Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Stability And Storage Services Market

• 19.1. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Stability And Storage Services Market

• 20.1. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Stability And Storage Services Market

• 21.1. Eastern Europe Pharmaceutical Stability And Storage Services Market Overview
• 21.2. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Stability And Storage Services Market

• 22.1. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Stability And Storage Services Market

• 23.1. North America Pharmaceutical Stability And Storage Services Market Overview
• 23.2. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Stability And Storage Services Market

• 24.1. USA Pharmaceutical Stability And Storage Services Market Overview
• 24.2. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Stability And Storage Services Market

• 25.1. Canada Pharmaceutical Stability And Storage Services Market Overview
• 25.2. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Stability And Storage Services Market

• 26.1. South America Pharmaceutical Stability And Storage Services Market Overview
• 26.2. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Stability And Storage Services Market

• 27.1. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Stability And Storage Services Market

• 28.1. Middle East Pharmaceutical Stability And Storage Services Market Overview
• 28.2. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Stability And Storage Services Market

• 29.1. Africa Pharmaceutical Stability And Storage Services Market Overview
• 29.2. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Stability And Storage Services Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Stability And Storage Services Market Competitive Landscape
• 30.2. Pharmaceutical Stability And Storage Services Market Company Profiles
  • 30.2.1. Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SGS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Stability And Storage Services Market Other Major And Innovative Companies

• 31.1. Intertek Group plc
• 31.2. Element Materials Technology Inc
• 31.3. Alloga UK Ltd.
• 31.4. ALS Limited
• 31.5. Pharmaceutical Contract Industries Pharma Services.
• 31.6. Almac Group
• 31.7. Alcami Corporation
• 31.8. BioLife Solutions Inc.
• 31.9. Auriga Research Private Limited
• 31.10. Reading Scientific Services Ltd.
• 31.11. Lucideon Limited
• 31.12. Q Laboratories Inc
• 31.13. PD Partners
• 31.14. Precision Stability Storage
• 31.15. Roylance Stability Storage Limited

32. Global Pharmaceutical Stability And Storage Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Stability And Storage Services Market

34. Recent Developments In The Pharmaceutical Stability And Storage Services Market

35. Pharmaceutical Stability And Storage Services Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Stability And Storage Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Stability And Storage Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Stability And Storage Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34925_Pharmaceutical_Stability_And_Storage_Services_GMR_2025